Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Left ventricular mass versus pulse wave velocity as predictors of coronary artery disease in hypertensive patients: data from a 6-year-follow-up study

Journal of Human Hypertension volume 36, pages 617–621 (2022)Cite this article

Subjects

Abstract

In treated hypertensive patients, there is a substantial residual cardiovascular (CV) risk that cannot be assessed by the available prediction models. This risk can be associated with subclinical organ damage, such as increased left ventricular mass (LVM) and arterial stiffness. However, it remains unknown which of these two CV markers better predicts coronary artery disease (CAD). A prospective cohort study was used to answer the above question. The study sample consisted of 1033 patients with hypertension (mean age 55.6 years, 538 males) free of CAD at baseline, who were followed for a mean period of 6 years. At baseline, all subjects underwent a complete echocardiographic study and pulse wave velocity (PWV) measurement. Hypertensive individuals who developed CAD (2.8%) compared to those without CAD at follow-up, had a higher baseline LVM index (by 16.7 g/m2, p < 0.001), higher prevalence of left ventricular hypertrophy (LVH) (21% greater, p = 0.027) and greater prevalence of high PWV levels at baseline (21% greater, p = 0.019). Multivariate Cox regression analysis revealed that baseline age >65 years (HR = 2.067, p = 0.001), male gender (HR = 3.664, p = 0.001), baseline chronic kidney disease (HR = 2.020, p = 0.026), baseline diabetes mellitus (HR = 1.952, p = 0.015) and baseline LVH (HR = 2.124 p = 0.001) turned out to be independent predictors of CAD, whereas high PWV levels were not. LVH proved to be an independent prognosticator of CAD in contrast to arterial stiffness that was not related to CAD after accounting for established confounders. Therefore, LVM can reliably help physicians to identify high-risk hypertensives in whom an intensified therapeutic management is warranted.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Life table analysis for the incidence of coronary artery disease.

Similar content being viewed by others

References

  1. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. ESC Scientific Document Group. 2016 European Guidelines on Cardiovascular Disease Prevention in Clinical Practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37:2315–81.

    Article  Google Scholar 

  2. Volpe M, Battistoni A, Tocci G, Rosei EA, Catapano AL, Coppo R, et al. Cardiovascular risk assessment beyond Systemic Coronary Risk Estimation: a role for organ damage markers. J Hypertens. 2012;30:1056–64.

    Article  CAS  Google Scholar 

  3. Sehestedt T, Jeppesen J, Hansen TW, Wachtell K, Ibsen H, Torp-Pedersen C, et al. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J. 2010;31:883–91.

    Article  Google Scholar 

  4. Ruilope LM, Schmieder RE. Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens. 2008;21:500–8.

    Article  Google Scholar 

  5. Cavalcante JL, Lima JA, Redheuil A, Al-Mallah MH. Aortic stiffness: current understanding and future directions. J Am Coll Cardiol. 2011;57:1511–22.

    Article  Google Scholar 

  6. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2018;36:2284–309.

    Article  CAS  Google Scholar 

  7. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. American Society of Echocardiography’s Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–63.

    Article  Google Scholar 

  8. Tsioufis C, Dimitriadis K, Selima M, Thomopoulos C, Mihas C, Skiadas I, et al. Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients. Eur Heart J. 2007;28:1162–9.

    Article  CAS  Google Scholar 

  9. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–S266.

    Google Scholar 

  10. Andrikou I, Tsioufis C, Dimitriadis K, Konstantinidis D, Kasiakogias A, Kouremeti M, et al. Uric acid as an independent predictor of coronary artery disease in essential hypertension: Data from an 8-year-follow-up study. Clin Exp Pharm Physiol. 2018;45:866–9.

    Article  CAS  Google Scholar 

  11. Zalawadiya SK, Gunasekaran PC, Bavishi CP, Veeranna V, Panaich S, Afonso L. Left ventricular hypertrophy and risk reclassification for coronary events in multi-ethnic adults. Eur J Prev Cardiol. 2015;22:673–9.

    Article  Google Scholar 

  12. Andrikou E, Tsioufis C, Thomopoulos C, Andrikou I, Kasiakogias A, Leontsinis I, et al. Left ventricular mass index as a predictor of new-onset microalbuminuria in hypertensive subjects: a prospective study. Am J Hypertens. 2012;25:1195–201.

    Article  CAS  Google Scholar 

  13. Gerdts E, Cramariuc D, de Simone G, Wachtell K, Dahlöf B, Devereux RB. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). Eur J Echocardiogr. 2008;9:809–15.

    Article  Google Scholar 

  14. Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension. 2000;35:580–6.

    Article  CAS  Google Scholar 

  15. Ben-Shlomo Y, Spears M, Boustred C, May M, Anderson SG, Benjamin EJ, et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol. 2014;63:636–46.

    Article  Google Scholar 

  16. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:1318–27.

    Article  Google Scholar 

  17. Kim HL, Kim SH. Pulse wave velocity in atherosclerosis. Front Cardiovasc Med. 2019;6:41.

    Article  Google Scholar 

  18. Verdecchia P, Angeli F, Gattobigio R, Sardone M, Pede S, Reboldi GP. Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects. Am J Hypertens. 2006;19:493–9.

    Article  Google Scholar 

  19. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS. LIFE Study Investigators et al. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA. 2004;292:2343–9.

    Article  CAS  Google Scholar 

  20. Frohlich ED. State of the art lecture. Risk mechanisms in hypertensive heart disease. Hypertension. 1999;34:782–9.

    Article  CAS  Google Scholar 

  21. Shlomai G, Grassi G, Grossman E, Mancia G. Assessment of target organ damage in the evaluation and follow-up of hypertensive patients: where do we stand? J Clin Hypertens. 2013;15:742–7.

    Article  Google Scholar 

  22. Smith SC Jr. Current and future directions of cardiovascular risk prediction. Am J Cardiol. 2006;97:28A–32A.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. First Cardiology Clinic, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece

    Ioannis Andrikou, Kyriakos Dimitriadis, Dimitris Konstantinidis, Ioannis Leontsinis, Eirini Andrikou, Panagiotis Iliakis, Ioannis Liatakis, Eleni Manta, Nikos Karaminas, Panagiotis Tsioufis, Nikolaos Magkas, Georgios Georgiopoulos, Christina Chrysohoou, Costas Thomopoulos, Dimitrios Tousoulis & Costas Tsioufis

Authors
  1. Ioannis Andrikou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kyriakos Dimitriadis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dimitris Konstantinidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ioannis Leontsinis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eirini Andrikou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Panagiotis Iliakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ioannis Liatakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Eleni Manta
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Nikos Karaminas
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Panagiotis Tsioufis
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Nikolaos Magkas
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Georgios Georgiopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Christina Chrysohoou
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Costas Thomopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Dimitrios Tousoulis
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Costas Tsioufis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Costas Tsioufis.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Andrikou, I., Dimitriadis, K., Konstantinidis, D. et al. Left ventricular mass versus pulse wave velocity as predictors of coronary artery disease in hypertensive patients: data from a 6-year-follow-up study. J Hum Hypertens 36, 617–621 (2022). https://doi.org/10.1038/s41371-021-00560-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41371-021-00560-1

Search

Advanced search

Quick links